SPDR Series Trust SPDR S&P Biotech ETF
เพิ่มขึ้น

XBI Bottoming: Target 103/104 by April 2024

XBI appears to be indicating signs of bottoming out, with a potential target range of 103/104 by the end of April 2024, provided that the 92/95 range holds as support.
Trend Analysis

และใน:

คำจำกัดสิทธิ์ความรับผิดชอบ